期刊文献+

卵巢癌腹膜后淋巴结转移的危险因素及MRI、CT影像特点观察 被引量:12

Risk Factors of Retroperitoneal Lymph Node Metastasis of Ovarian Cancer and its Image Features of MRI and CT
暂未订购
导出
摘要 目的分析卵巢癌腹膜后淋巴结转移的危险因素,并观察其MRI、CT影像特点。方法将资阳市第一人民医院自2014年1月至2018年5月收治的有明确手术病理诊断结果,且术前CT、MRI影像资料完整无缺失的89例原发性卵巢癌患者纳入研究范围,先行单因素分析,再筛选单因素分析有差异选项进一步Logistic回归分析卵巢癌腹膜后淋巴结转移的危险因素,同时观察MRI、CT影像特点。结果双侧卵巢癌患者腹膜后淋巴结转移率显著高于单侧(左侧或右侧),上皮性卵巢癌患者转移率显著高于非上皮性卵巢癌,低分化上皮性卵巢癌患者转移率显著高于高分化、中分化患者,临床分期Ⅳ期转移率>Ⅲ期>Ⅱ期>Ⅰ期,首次细胞减灭术后残留病灶直径>2cm患者转移率显著大于残余病灶直径≤2cm、0cm患者,术前有腹腔化疗的卵巢癌患者转移率显著高于无腹腔化疗患者,1期手术患者转移率显著高于2期,差异均有统计学意义(P<0.05);Logistic回归分析,临床分期、首次细胞减灭术后残留病灶直径是卵巢癌腹膜后淋巴结转移的危险因素(P<0.05);CT诊断卵巢癌腹膜后淋巴结转移的灵敏度为88.63%、特异度为97.26%、准确率为94.01%,阳性预测值95.12%、阴性预测值93.42%、kappa值0.870;MRI则为98.86%、99.326%、99.15%、98.86%、99.32%、0.981。结论临床分期、首次细胞减灭术后残留病灶直径是卵巢癌腹膜后淋巴结转移的危险因素,应引起临床重视,且CT、MRI均对腹膜后淋巴结转移均有一定显示,或可为卵巢癌患者治疗方案的制定提供影像学资料。 Objective To analyze the risk factors of retroperitoneal lymph node metastasis of ovarian cancer,to observe its images characteristics of MRI and CT.Methods 89 primary ovarian cancer patients with clear surgical pathological diagnosis results and preoperative complete CT and MRI images data in the hospital from January 2014 to May 2018 were enrolled in the study.Univariate analysis was performed firstly,Logistic regression analysis was used to analyze the different options screened by univariate analysis which were the risk factors of retroperitoneal lymph node metastasis in ovarian cancer,the image features of MRI and CT were observed.Results The rate of retroperitoneal lymph node metastasis was significantly higher in patients with bilateral ovarian cancer than that with unilateral ovarian cancer (left or right side).The metastatic rate of patients with epithelial ovarian cancer was significantly higher than that of patients with non-epithelial ovarian cancer.The metastatic rate of patients with poorly differentiated epithelial ovarian cancer was significant higher than that of patients with high and medium differentiation.Arranging the metastasis rate from high to low,the order was stage Ⅳ,Ⅲ stage,Ⅱ stage and Ⅰ stage,the metastasis rate in patients with the residual lesions diameter greater than 2cm after first cytoreductive surgery was significantly greater than that in patients with residual lesions diameter less than or equaling to 2cm and 0cm.The metastasis rate in ovarian cancer patients with intraperitoneal chemotherapy was significantly higher than that in patients without intraperitoneal chemotherapy.The metastasis rate of patients with stage 1 surgery was significantly higher than that in patients with stage 2 (P<0.05).Logistic regression analysis showed that clinical stage,the diameter of residual lesions after cytoreductive surgery were the risk factors for retroperitoneal lymph node metastasis of ovarian cancer (P<0.05).The sensitivity,specificity,accuracy,positive predictive value,negative predictive value and the kappa value for the diagnosis of retroperitoneal lymph node metastasis of ovarian cancer with CT were 88.63%,97.26%,94.01%,95.12%,93.42% and 0.870,respectively,the above 6 indexes with MRI were 98.86%,99.326%,99.15%,98.86%,99.32%,and 0.981,respectively.Conclusion The clinical stage,the diameter of residual lesions after first cytoreductive surgery are the risk factors for retroperitoneal lymph node metastasis of ovarian cancer,which should be paid attention to clinically.Both CT and MRI have certain indications for retroperitoneal lymph node metastasis,which may provide imaging data for the development of therapeutic regimens of ovarian cancer patients.
作者 付信飞 马青松 黎俊 FU Xin-fei;Ma Qing-song;LI Jun(Department of Medical Imaging,First People's Hospital,Ziyang 641300,Sichuan Province,China)
出处 《中国CT和MRI杂志》 2020年第9期134-138,共5页 Chinese Journal of CT and MRI
关键词 卵巢恶性肿瘤 腹膜后淋巴结转移 危险因素 MRI CT Malignant Ovarian Tumor Retroperitoneal Lymph Node Metastasis Risk Factors MRI CT
  • 相关文献

参考文献9

二级参考文献106

  • 1Gozde Kir,Ayse Gurbuz,Ates Karateke,Mustafa Kir.Clinicopathologic and immunohistochemical profile of ovarian metastases from colorectal carcinoma[J].World Journal of Gastrointestinal Surgery,2010,2(4):109-116. 被引量:13
  • 2江新青,谢琦,夏建东,梁长虹,彭国晖,张静,叶伟军,高剑民,郑力强,梁志伟.宫颈癌放疗后盆腔MRI分析[J].中华放射学杂志,2004,38(7):721-725. 被引量:10
  • 3姚晋,闵鹏秋,黄娟.腹膜转移瘤的CT征象[J].中国普外基础与临床杂志,2005,12(6):620-623. 被引量:10
  • 4赫捷,陈万青.2012中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:12-25.
  • 5Kaur H, Silverman PM, Iyer RB, et al. Diagnosis, staging, and surveillance of cervical carcinoma[J].AJR Am J Roentgenol, 2003, 180 (6): 1621-1631.
  • 6Engin G. Cervical cancer: MR imaging findings before, during, and after radiation therapy[J].Eur Radiol, 2006, 16 (2):313-324.
  • 7Sala E, Rockall AG, Freeman SJ, et al. The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know [J].Radialogy, 2013, 266(3):717-740.
  • 8Rauch GM, Kaur H, Choi H, et al. Optimization of MR imaging for pretreatment evaluation of patients with endometrial and cervical cancer[J].Radiographics, 2014, 34 (4):1082-1098.
  • 9Henderson E, Rutt BK, Lee TY. Temporal sampling requirements for the tracer kinetics modeling of breast disease [J].Magn Reson Imaging, 1998, 16(9):1057-1073.
  • 10Turkbey B, Aras O, Karabulut N, et al. Diffusion-weighted MRI for detecting and monitoring cancer: a review of current applications in body imaging[J].Diagn Interv Radiol, 2012, 18 ( 1 ):46-59.

共引文献123

同被引文献111

引证文献12

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部